Dr. Joan Reibman, MD
- Part D claims, 2024
- 889
- Publications
- 93
- Clinical trials
- 3
- Hospital affiliations
- 1
- Industry payments
- $144,068
- Practice address
- 462 First Avenue, New York, NY 10016
- Practice phone
- Call (212) 561-4132
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Reibman's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Joan Reibman is a pulmonologist in New York, New York
Dr. Reibman practices at NYC Health + Hospitals/Bellevue in New York, New York, part of NYC.
Dr. Reibman's NPI, 1265649933, was assigned on May 16, 2007. Dr. Reibman graduated from Johns Hopkins University School of Medicine in 1979. Dr. Reibman holds New York license 147102.
- NPI
- 1265649933NPI Registry (opens in a new tab)
- NPI enumeration date
- May 16, 2007
- NPI status
- Active
- Practice phone
- (212) 561-4132
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Medical school graduation
- 1979
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Joan Reibman practices at NYC Health + Hospitals/Bellevue in New York, New York
Dr. Reibman's primary practice is NYC Health + Hospitals/Bellevue, at 462 First Avenue, New York, NY 10016 in New York County. The practice phone is (212) 561-4132.
- NYC Health + Hospitals/Bellevue462 First Avenue, New York, NY 10016 · New York CountyPhone(212) 561-4132
Source: Dmand AI Affiliation Data
Dr. Joan Reibman is affiliated with 1 site of care
Dr. Reibman's primary practice is NYC Health + Hospitals/Bellevue in New York, New York, part of NYC. Dr. Reibman's employer is on file too: a hospital.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Joan Reibman's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reibman practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| NYC Health + Hospitals/Bellevue | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across NYC and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Joan Reibman is one of 1,056 pulmonologists in New York
Pulmonary disease is Dr. Reibman's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Reibman is licensed in New York.
Specialties and state licenses
- Pulmonary disease, New YorkPrimary
Pulmonologists near Dr. Reibman
Counts of pulmonologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Joan Reibman's patients have a median age of 68
Across all payers, Dmand AI patient panel data puts Dr. Reibman's median patient age at 68, with 77% women.
Dr. Reibman's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women77%
- Men23%
Source: Dmand AI Patient Panel Data
Dr. Joan Reibman wrote 889 Medicare Part D claims in 2024
In 2024, Dr. Reibman wrote 889 Medicare Part D claims for 115 patients. 49% of them were for generic drugs. CMS names the drug for 787 of them, across 20 drugs with 11 or more claims each, at $288,741 in total drug cost. In 2023, CMS named 988 claims across 20 drugs.
Dr. Reibman's Part D claims by kind of drug, 2024
- Generic432 claims49%
- Brand-name457 claims51%
Dr. Reibman's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 9882024: 78720%
Drugs named by CMS: 20 in 2024, 20 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Joan Reibman has 93 publications on record
Dmand AI links 93 papers to Dr. Reibman, published from 2010 to 2024. 2022 was the busiest year, with 12. The most frequent topics are September 11 Terrorist Attacks, New York City and Asthma. Dr. Reibman has published most often in Int J Environ Res Public Health. Dr. Reibman's most frequent co-authors are Kenneth Berger, MD, Robert Wise, MD and David A. Beuther, MD.
Dr. Reibman's papers by year, 2015 to 2024
Topics Dr. Reibman writes about most
- September 11 Terrorist Attacks
- New York City
- Asthma
- Dust
- Environmental Exposure
- Spirometry
- Air Pollutants
- Forced Expiratory Volume
Dr. Reibman's most frequent co-authors
- Kenneth Berger, MD23 shared papers
- Robert Wise, MD11 shared papers
- David A. Beuther, MD9 shared papers
Recent publications by Dr. Reibman
Arch Environ Occup Health
See who Dr. Reibman researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Reibman works with, so you can find a warm path to the right pulmonologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Joan Reibman has worked on 3 clinical trials
Dmand AI links Dr. Reibman to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Asthma, Lung Diseases and Medication Adherence. NYU Langone Health sponsors the most, 2.
Conditions in Dr. Reibman's trials
- Asthma
- Lung Diseases
- Medication Adherence
- Patient Compliance
- Respiratory Hypersensitivity
Investigators on the most trials with Dr. Reibman
Recent clinical trials with Dr. Reibman
In Situ Analysis of Sputum-derived Cellular Targets After Xolair (Omalizumab). (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Joan Reibman received $144,068 in industry payments from 2016 to 2025
CMS Open Payments shows 152 general payments to Dr. Reibman from 4 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 87% of the total. AstraZeneca Pharmaceuticals LP paid the most, $135,416.
General payments to Dr. Reibman by program year, 2016 to 2025
General payments to Dr. Reibman by kind, 2016 to 2025
- Consulting fees$125,85187%
- Travel and lodging$7,6945%
- Speaker and faculty fees$6,9285%
- Food and beverage$3,5342%
- Education$620%
Companies that paid Dr. Reibman the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Joan Reibman graduated from Johns Hopkins University School of Medicine
Dr. Reibman graduated from Johns Hopkins University School of Medicine in 1979.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Joan Reibman's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Joan Reibman
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Joan Reibman's NPI number?
Dr. Joan Reibman's NPI number is 1265649933. It was assigned on May 16, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Joan Reibman?
Dr. Joan Reibman is a pulmonologist in New York, New York. The primary specialty in the NPI Registry is Pulmonary Disease Physician (taxonomy code 207RP1001X).
Where does Dr. Joan Reibman practice?
Dr. Reibman practices at 462 First Avenue, New York, NY 10016. Dr. Reibman's primary practice is NYC Health + Hospitals/Bellevue in New York, New York, part of NYC.
What is Dr. Joan Reibman's office phone number?
The practice phone on file for Dr. Reibman is (212) 561-4132.
What is Dr. Joan Reibman's medical license number?
Dr. Reibman holds New York license 147102.
Which hospitals is Dr. Joan Reibman affiliated with?
Dr. Reibman practices at NYC Health + Hospitals/Bellevue in New York, New York.
Where did Dr. Joan Reibman go to medical school?
Dr. Reibman graduated from Johns Hopkins University School of Medicine in 1979.
What drugs does Dr. Joan Reibman prescribe most?
In 2024 Medicare Part D data, Dr. Reibman's most prescribed drugs by claims were Albuterol Sulfate Hfa, Prednisone and Fluticasone Propionate.
Has Dr. Joan Reibman received payments from drug or device companies?
CMS Open Payments shows $144,068 in general payments to Dr. Reibman from 4 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Joan Reibman been practicing?
Dr. Reibman graduated from medical school in 1979, 47 years ago.
Does Dr. Joan Reibman do research?
Dmand AI links 93 publications to Dr. Reibman, published from 2010 to 2024. Dr. Reibman has worked on 3 clinical trials.
Who does Dr. Joan Reibman publish with?
Dr. Reibman's most frequent co-authors are Kenneth Berger, MD (23 shared papers), Robert Wise, MD (11 shared papers) and David A. Beuther, MD (9 shared papers).
Selling to pulmonary disease practices?
See pulmonologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card